BACKGROUND
There are presently no available therapeutic options for patients with peanut allergy.
OBJECTIVE
We sought to investigate the safety, efficacy, and immunologic effects of peanut sublingual immunotherapy (SLIT).
METHODS
After a baseline oral food challenge (OFC) of up to 2 g of peanut powder (approximately 50% protein; median successfully consumed dose [SCD], 46 mg), 40 subjects, ...